Pharmacokinetics and Pharmcodynamics Flashcards
The drug’s effect on the body is called?
pharmacodynamics
pharmacodynamics includes:
therapeutic and toxic effects of drugs -sensitivity and responsiveness of receptors (varies patient to patient) -mechanism of action effective dose
a substance that binds to a specific receptor and triggers a response in the cell; mimics the action of an endogenous ligand that binds to the same receptor
agonist
(drug will probably have an increased effect of the same actions on receptors, ex: Sch has same effect as Ach but not metabolized as quickly so lasts longer)
effect not to the full degree
partial agonist
causes maximal activation of all receptors
full agonist
a drug that has affinity for the receptor, but no efficacy
antagonist
Describe the action of an antagonist
-does not activate the receptor to produce a physiologic action
-combination with receptor may block a response, so it does have a physiologic consequence
-typically has higher affinity for receptor than the agonist
(Narcan sometime higher affinity for opioid receptors and may even knock opioid off of receptor)
what is the difference between competitive and noncompetitive antagonists?
- competitive antagonists may be overwhelmed if enough agonist is built up and forces the antagonist off the receptor
- noncompetitive antagonists bind to the receptor and does not come off; a new receptor must be generated allowing a longer effect since it takes time to synthesize a new receptor
what are the two types of antagonism?
- physiologic antagonism: two agonist drugs bind to different receptors, causing opposing responses
- ex: alpha1 agonist causes vasoconstriction, beta2 agonist causes vasodilation
- chemical antagonism: no receptor activity involved; one drug binds with 2nd drug to inactivate it
- ex: protamine binds with heparin eliminating anticoagulation effect but with no heparin, protamine is an anticoagulant
possibly have both agonist and antagonist effects; activates a receptor, but cannot produce a maximum response (lower efficacy); may partially block effect of full agonists
partial agonist or agonist-antagonist
when are agonist-antagonist drugs commonly used
- in labor and delivery since you don’t want the maximum opioid effect crossing the placenta
ex: Nubain and Stadol act as agonists for some opioid receptors and antagonize others; antagonize MU-II opioid receptors to block respiratory depression but may have some effect on some MU-I receptors affecting analgesic effect of opioids
component of a cell that interacts with a drug and initiates the chain of events leading to the drug’s effect
receptor
describe receptors
- can be extracellular and can go through from outside to inside
- responsible for selectivity of drug action
- mediate actions of both agonist and antagonists
- affinity of receptor for a drug and the number of receptors may limit the maximal effect of a drug
the degree of drug receptor interaction for a given drug; the attraction between drug and receptor
affinity
differentiates between different agonists that activate the same receptor, can all produce the same maximal response, but a differing concentrations
potency
a drug’s ability to produce the desired response expected by stimulation of a given receptor; the maximum effect that can be achieved with the drug
“intrinsic activity”
efficacy
explain the spare receptor concept.
maximal or nearly maximal response can often be produced by activation of only a fraction of the receptors present; relationship between the number of receptors stimulated and the response is usually nonlinear (an increased number of receptors stimulated does not mean an increase in response)
how does the spare receptor concept effect muscle receptors and antagonists?
It takes 70% of receptors blocked before reduction in muscle response is seen; showing that only 30% of the receptors must be activated by Ach to produce a maximal muscle response
- it takes 90% of muscle receptors blocked by muscle relaxants for surgical relaxation
- once decreased to only 70% blocked, considered fully recovered
desensitization with agonists; repeated use causes body to decrease the number of receptors and effect is diminished
down-regulation
- tolerance
ex: beta agonist bronchodilators (albuterol)- tolerance develops from repeated use and an increased dose is required for the same effect
chronic exposure to antagonists cause receptor number and sensitivity to increase
up-regulation
ex: beta blockers cause up regulation of receptors
* reason you don’t stop beta blockers before surgery; increase in receptors will lead to a major reaction
What factors affect pharmacologic response?
age, sex, weight, body surface area, basal metabolic rate, pathologic state, genetic profile
the actions of the body on the drug
pharmacokinetics
what are the stages of pharmacokinetics
- absorption
- distribution
- metabolism
- elimination of drugs and metabolites
what is the first pass effect of absorption?
the liver extracts and or metabolizes the drug first before it goes to the site of action causing a lesser amount of drug getting to the site
- reason for difference in effect of po and IV doses
- po and rectal routes go through first pass effect
- sublingual is absorbed directly into the superior vena cava
what effects does ionized vs. nonionized have on distribution?
-ionized charged, water soluble not lipid soluble; do not cross the BBB *smaller distribution -nonionized no charge; lipid soluble *larger volume of distribution *cross lipid bilayers like BBB, GI, hepatocytes, renal tubular and placenta ex: muscle relaxants are water soluble, do not cross the BBB, so must give a sedative that can cross the BBB